Healthy Ventures

Healthy Ventures is one of the few US seed firms whose entire reason for existing is healthcare IT and digital health, and that singular focus changes the kind of conversation founders have with the partners. The firm operates out of San Francisco, writes $1M-$5M checks at pre-seed and seed, and has spent years building a thesis around the boring but essential infrastructure layer of healthcare: the data plumbing, workflow tools, payer-provider connective tissue, and care delivery software that the system actually runs on rather than the consumer-facing apps that get more attention.

The declared focus is health IT software and digital health, with an explicit AI lens. The kinds of companies that fit are infrastructure plays around interoperability, claims and revenue cycle, prior authorization, clinical workflow, value-based care enablement, and AI tooling that sits underneath healthcare operations rather than on top of patient experience. Healthy Ventures is generally less excited about direct-to-consumer wellness, single-disease telehealth, or therapeutics. The portfolio bias is toward companies whose customers are health systems, payers, and large provider groups, with revenue that compounds through enterprise sales rather than consumer churn.

Check sizes of $1M-$5M at pre-seed and seed mean the firm is willing to lead or co-lead and to take meaningful ownership in early rounds. That positioning lets it stay involved through follow-on rounds and exert real board-level influence on the companies it backs. Geographically the firm is concentrated on US healthcare, where regulatory and reimbursement complexity creates the moats that make enterprise healthcare software a durable category. Founders pitching from outside the US should expect questions about how a non-US healthcare context translates into the firm’s enterprise thesis.

The team is small and concentrated, with partners who have spent careers inside healthcare investing and operating roles. Diligence tends to be deep on the specific workflow being addressed, the buyer dynamics inside the customer organization, and the realistic shape of an enterprise sales motion in healthcare. Founders should be ready for direct, informed questions about how procurement, clinical buy-in, and regulatory dynamics will actually unfold in their first ten customers.

For founders, the practical read is that Healthy Ventures is a credible early lead for healthcare IT software companies, particularly those building infrastructure for providers and payers. It is less useful for consumer health, for therapeutics, or for founders who want a generalist seed fund that does not care about healthcare specifics. The engagement style is high-context and hands-on, with real time spent on go-to-market, hiring, and follow-on fundraising. Founders building enterprise healthcare software and looking for a focused early-stage partner with deep domain fluency will find this firm one of the more deliberate and committed options in the seed-stage healthcare landscape.